10.1002/anie.201915155
Angewandte Chemie International Edition
COMMUNICATION
replaced OXCMe by the Y497A variant, mandelic acid production
rate increased 5-fold and the conversion increased 4-fold
(Figure 1E). This was likely caused by decreased formation of the
unwanted side product formyl-CoA (and its further hydrolysis by
YciA). Chiral LC-MS revealed that (S)-mandelic acid was
produced with enantiomeric excess of 97% (Figure 1D). Since
YciA showed no stereospecificity in the hydrolysis of mandelyl-
CoA (Figure 1B), the stereochemistry is exclusively determined
The rational engineering of OXCMe-Y497A enabled a three
enzyme cascade comprising of OXS, a newly identified oxalyl-
CoA synthetase, and YciA, an efficient mandelyl-CoA
thioesterase with only minor formyl- and oxalyl-CoA hydrolysis
activities. The OXCMe-mediated production of aromatic (S)-α-
hydroxy acids in high ee from aldehydes and oxalate offers an
alternative to hydrogen cyanide based syntheses catalyzed by
nitrilases.[21] However, the requirements of CoA in catalytic
amounts and an ATP regeneration system may limit the potential
for a synthetic application on the larger scale. To this end,
employing whole-cell catalysts may prove to be advantageous,
providing not only the cascade enzymes but also ATP
regeneration and a CoA pool without addition of purified enzymes
and cofactors.[22]
by OXCMe
.
Next, we tested the substrate scope of the catalytic cycle by
replacing benzaldehyde with substituted variants 2i-2k (Figure
2A). Under limiting ATP concentrations (10 mM), the expected
products 3a-3d were formed at varying yields (57-93%) and ee
(44-99%) (Figure 2B). Notably, also sterically demanding 2k was
converted to 3d with high yield, albeit with moderate ee. The
broad substrate scope of the OXS-OXC-YciA cascade was further
confirmed by an extended screen, in which product formation was
detected for ten other aromatic and three heteroaromatic
aldehydes (3e-3r, Figure 2C). To test if the cascade can be scaled
up, we performed the reaction on a semi-preparative scale (0.625
mmol 2h). We added an ATP regeneration system comprising of
creatine phosphate, creatine kinase and adenylate kinase. With
catalytic amounts of ADP (0.5 mM) this five enzyme one-pot
cascade produced 3a with a yield of 53%. Taken together, these
results indicate that the established enzyme cascade can be
employed to produce various aromatic α-hydroxy acids with
moderate to high (S)-selectivity.
Altogether, our study expands the spectrum of ThDP-
dependent transformations by nucleophilic C1-extensions, which
gives access to α-hydroxy acids that are valuable chiral building
blocks and showcases ways to establish in vitro- and in vivo-
platforms for the continuous production of these compounds in
the future.
Experimental Section
Experimental Details can be found in the Supporting Information.
We demonstrated that members of the OXC/HACL
superfamily are able to catalyze C1-carboligation reactions
between 1 – formed either through decarboxylation of oxalyl-CoA
or deprotonation of formyl-CoA – and several aldehydes to yield
chiral 2-hydroxyacyl-CoA thioesters. These nucleophilic C1-
extension reactions expand the spectrum of ThDP-dependent
enzymes as versatile biocatalysts for C-C bond forming
reactions.[19]
What determines substrate specificity in the OXC/HACL
superfamily? The observed variance in the aldehyde scope of
OXCMe and HACLHs are likely caused by differences in the C-
terminal domain, which forms a ‘lid’ on top of the active site.[10a]
While the bottom part of the active site is virtually identical
between OXC and HACL (with exception of Tyr133 and Glu134
in OXCMe that are replaced by Phe and Gln in HACLHs), the C-
terminal lid-domain shows a high variability between individual
superfamily members. Further characterization of the OXC/HACL
superfamily could reveal more carboligases with aldehyde
preference for a desired application.
We engineered OXCMe towards improved carboligation rate at
the expense of formyl-CoA formation rate by replacing Tyr497
with Ala. Interestingly, the mutation Y497A did not affect the
enantioselectivity for (S)-mandelyl-CoA. This is reminiscent of
engineering efforts on PDC from Zymomonas mobilis, where
Glu473 positions a water molecule that acts as proton donor for
the ThDP carbanion/enamine intermediate. Mutating this amino
acid to glutamine led to a 100-fold preference of carboligation over
aldehyde release, under full retention of enantioselectivity.[13]
Considering the high demand of mandelic acid and its derivatives
in the (R) configuration,[16] it would be interesting to engineer
OXCMe towards inverted enantioselectivity. This has been
achieved for other ThDP-dependent carboligases.[20]
Acknowledgements
We thank L. Schulz for cloning of oxc and B. Heinrich for NMR
measurements. This work was supported by the German Ministry
of Education and Research Grant FormatPlant (part of
BioEconomy 2030, Plant Breeding Research for the Bioeconomy).
A provisional patent application has been filed through the Max-
Planck-Innovation based on the results presented here.
Keywords: oxalyl-CoA decarboxylase • thiamine diphosphate •
C-C coupling • C1 building blocks • biocatalysis
[1]
[2]
R. Kluger, K. Tittmann, Chem. Rev. 2008, 108, 1797-1833.
U. Schörken, G. A. Sprenger, Biochim. Biophys. Acta 1998, 1385,
229-243.
[3]
[4]
A. S. Demir, T. Dünnwald, H. Iding, M. Pohl, M. Müller,
Tetrahedron Asymmetry 1999, 10, 4769-4774.
A. S. Demir, O. Sesenoglu, E. Eren, B. Hosrik, M. Pohl, E. Janzen,
D. Kolter, R. Feldmann, P. Dünkelmann, M. Müller, Adv. Synth.
Catal. 2002, 344, 96-103.
[5]
a) P. Payongsri, D. Steadman, J. Strafford, A. MacMurray, H. C.
Hailes, P. A. Dalby, Org. Biomol. Chem. 2012, 10, 9021-9029; b)
M. L'enfant, F. Bruna, M. Lorilliere, N. Ocal, W. D. Fessner, L.
Pollegioni, F. Charmantray, L. Hecquet, Adv. Synth. Catal. 2019,
361, 2550-2558; c) A. Ranoux, S. K. Karmee, J. F. Jin, A. Bhaduri,
A. Caiazzo, I. W. C. E. Arends, U. Hanefeld, ChemBioChem 2012,
13, 1921-1931.
[6]
[7]
a) G. A. Olah, Angew. Chem. Int. Ed. 2013, 52, 104-107; b) O.
Yishai, S. N. Lindner, J. G. de la Cruz, H. Tenenboim, A. Bar-
Even, Curr. Opin. Chem. Biol. 2016, 35, 1-9.
J. B. Siegel, A. L. Smith, S. Poust, A. J. Wargacki, A. Bar-Even, C.
Louw, B. W. Shen, C. B. Eiben, H. M. Tran, E. Noor, J. L. Gallaher,
This article is protected by copyright. All rights reserved.